{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:37:30Z","timestamp":1759412250530},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1038\/ejhg.2012.278","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T11:22:59Z","timestamp":1355916179000},"page":"1000-1006","source":"Crossref","is-referenced-by-count":7,"title":["Genomic correlates of variability in immune response to an oral cholera vaccine"],"prefix":"10.1038","volume":"21","author":[{"given":"Partha P","family":"Majumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeta","family":"Sarkar-Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Staats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujit","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goutam","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol C","family":"Whisnant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane K","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"BFejhg2012278_CR1","first-page":"309","volume":"84","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Cholera: global surveillance summary, 2008. Weekly Epid Rec 2009; 84: 309\u2013324.","journal-title":"Weekly Epid Rec"},{"key":"BFejhg2012278_CR2","first-page":"526","volume":"50","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Meeting of the Strategic Advisory Group of Experts on immunization October 2009\u2013conclusions and recommendations. Weekly Epid Rec 2009; 50: 526\u2013528.","journal-title":"Weekly Epid Rec"},{"key":"BFejhg2012278_CR3","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3201\/eid1711.110822","volume":"17","author":"KA Date","year":"2011","unstructured":"Date KA, Vicari A, Hyde TB et al: Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti 2010-2011. Emerg Infect Dis 2011; 17: 2105\u20132112.","journal-title":"Emerg Infect Dis"},{"key":"BFejhg2012278_CR4","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3201\/eid1711.110827","volume":"17","author":"JW Tappero","year":"2011","unstructured":"Tappero JW, Tauxe-Emer RV : Lessons learned during public health response to cholera epidemic in haiti and the dominican republic. Emerg Infect Dis 2011; 17: 2087\u20132093.","journal-title":"Emerg Infect Dis"},{"key":"BFejhg2012278_CR5","unstructured":"Institute of Medicine: New Vaccine Development Establishing Priorities Volume II Diseases of Importance in Developing Countries. Washington DC: National Academy Press, 1986."},{"key":"BFejhg2012278_CR6","first-page":"325","volume":"86","author":"World Health Organization:","year":"2011","unstructured":"World Health Organization:: Cholera, 2010. Weekly Epid Rec 2011; 86: 325\u2013340.","journal-title":"Weekly Epid Rec"},{"key":"BFejhg2012278_CR7","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1371\/journal.pntd.0001003","volume":"5","author":"ET Ryan","year":"2011","unstructured":"Ryan ET : The cholera pandemic still with us after half a century Time to rethink. PLoS Negl Trop Dis 2011; 5: e1003.","journal-title":"PLoS Negl Trop Dis"},{"key":"BFejhg2012278_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1099\/00222615-42-4-251","volume":"42","author":"RK Nandy","year":"1995","unstructured":"Nandy RK, Sengupta TK, Mukhopadhyay S, Ghosh AC : A comparative study of the properties of Vibrio cholera 0139 01 and other non-01 strains. J Med Microbiol 1995; 42: 251\u2013257.","journal-title":"J Med Microbiol"},{"key":"BFejhg2012278_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","volume":"143","author":"MM Levine","year":"1981","unstructured":"Levine MM, Black RE, Clements ML, Cisneros L, Nalin DR, Young CR : Duration of infection-derived immunity to cholera. J Infect Dis 1981; 143: 818\u2013820.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR10","unstructured":"World Health Organization: Global Task Force on Cholera Control. Cholera Vaccines A new public health tool? Report of a WHO meeting 10\u201311 December 2002 Geneva Switzerland World Health Organization 2002, pp 14."},{"key":"BFejhg2012278_CR11","doi-asserted-by":"crossref","unstructured":"Sinclair D, Abba K, Zaman K, Qadri F, Graves PM : Oral vaccines for preventing cholera. Cochrane Database Syst Rev 2011; (Issue 3): Art No CD008603.","DOI":"10.1002\/14651858.CD008603.pub2"},{"key":"BFejhg2012278_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1348-0421.2006.tb03866.x","volume":"50","author":"D Provenzano","year":"2006","unstructured":"Provenzano D, Kov\u00e1c P, Wade WF : The ABCs (Antibody B cells and Carbohydrate epitopes) of cholera immunity considerations for an improved vaccine. Microbiol Immunol 2006; 50: 899\u2013927.","journal-title":"Microbiol Immunol"},{"key":"BFejhg2012278_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","volume":"159","author":"JD Clemens","year":"1989","unstructured":"Clemens JD, Sack DA, Harris JR et al: ABO blood groups and cholera new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis 1989; 159: 770\u2013773.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114050","volume":"121","author":"RI Glass","year":"1985","unstructured":"Glass RI, Holmgren J, Haley CE et al: Predisposition for cholera of individuals with O blood groupPossible evolutionary significance. Am J Epidemiol 1985; 121: 791\u2013796.","journal-title":"Am J Epidemiol"},{"key":"BFejhg2012278_CR15","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.1128\/IAI.73.11.7422-7427.2005","volume":"73","author":"JB Harris","year":"2005","unstructured":"Harris JB, Khan AI, LaRocque RC et al: Blood group immunity and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun 2005; 73: 7422\u20137427.","journal-title":"Infect Immun"},{"key":"BFejhg2012278_CR16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/IAI.63.2.707-709.1995","volume":"63","author":"R Lagos","year":"1995","unstructured":"Lagos R, Avenda\u00f1o A, Prado V et al: Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titres in persons of blood group O. Infect Immun 1995; 63: 707\u2013709.","journal-title":"Infect Immun"},{"key":"BFejhg2012278_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1128\/CVI.00123-10","volume":"17","author":"T Ramamurthy","year":"2010","unstructured":"Ramamurthy T, Wagener D, Chowdhury G, Majumder PP : A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response. Clin Vaccine Immunol 2010; 17: 1232\u20131237.","journal-title":"Clin Vaccine Immunol"},{"key":"BFejhg2012278_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1086\/301736","volume":"62","author":"GA Poland","year":"1998","unstructured":"Poland GA : Variability in immune response to pathogens using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet 1998; 62: 215\u2013220.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2012278_CR19","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0264-410X(98)00362-4","volume":"17","author":"GA Poland","year":"1999","unstructured":"Poland GA, Jacobson RM, Colbourne SA et al: Measles antibody seroprevalence rates among immunized Inuit Innu and Caucasian subjects. Vaccine 1999; 17: 1525\u20131531.","journal-title":"Vaccine"},{"key":"BFejhg2012278_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1568-9972(03)00031-4","volume":"2","author":"DR Milich","year":"2003","unstructured":"Milich DR, Leroux-Roels GG : Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2003; 2: 248\u2013257.","journal-title":"Autoimmun Rev"},{"key":"BFejhg2012278_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1096-9071(199612)50:4<283::AID-JMV1>3.0.CO;2-4","volume":"50","author":"JN Zuckerman","year":"1996","unstructured":"Zuckerman JN : Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol 1996; 50: 283\u2013288.","journal-title":"J Med Virol"},{"key":"BFejhg2012278_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4161\/hv.4.4.5824","volume":"4","author":"D Gupta","year":"2008","unstructured":"Gupta D, Faridi MM, Aggarwal A, Kaur I : Seroprevalence of anti-Vi antibodies and immunogenicity of Typhim Vi vaccine in children. Hum Vaccine 2008; 4: 305\u2013308.","journal-title":"Hum Vaccine"},{"key":"BFejhg2012278_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa0807521","volume":"361","author":"D Sur","year":"2009","unstructured":"Sur D, Ochiai RL, Bhattacharya SK et al: A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009; 361: 403\u2013405.","journal-title":"N Engl J Med"},{"key":"BFejhg2012278_CR24","first-page":"201","volume":"10","author":"TG Kimman","year":"2007","unstructured":"Kimman TG, Vandebriel RJ, Hoebee B : Genetic variation in the response to vaccination. Community Genet 2007; 10: 201\u2013217.","journal-title":"Community Genet"},{"key":"BFejhg2012278_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.175.2.495","volume":"175","author":"MS Kruskall","year":"1992","unstructured":"Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D : The immune response to hepatitis B vaccine in humans inheritance patterns in families. J Exp Med 1992; 175: 495\u2013502.","journal-title":"J Exp Med"},{"key":"BFejhg2012278_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1086\/338014","volume":"185","author":"CM Gelder","year":"2002","unstructured":"Gelder CM, Lambkin R, Hart KW et al: Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002; 185: 114\u2013117.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR27","doi-asserted-by":"publisher","first-page":"D35","DOI":"10.1016\/j.vaccine.2008.07.065","volume":"26","author":"GA Poland","year":"2008","unstructured":"Poland GA, Ovsyannikova IG, Jacobson RM : Immunogenetics of seasonal influenza vaccine response. Vaccine 2008; 26: D35\u2013D40.","journal-title":"Vaccine"},{"key":"BFejhg2012278_CR28","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1016\/j.vaccine.2008.06.057","volume":"26","author":"GA Poland","year":"2008","unstructured":"Poland GA, Ovsyannikova IG, Jacobson RM : Vaccine immunogenetics bedside to bench to population. Vaccine 2008; 26: 6183\u20136188.","journal-title":"Vaccine"},{"key":"BFejhg2012278_CR29","first-page":"287","volume":"52","author":"W van Eden","year":"1983","unstructured":"van Eden W, de Bries RRP, Stanford JL, Rook GAW : HLADR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol 1983; 52: 287\u2013292.","journal-title":"Clin Exp Immunol"},{"key":"BFejhg2012278_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/hep.20142","volume":"39","author":"C Wang","year":"2004","unstructured":"Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA : HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004; 39: 978\u2013988.","journal-title":"Hepatology"},{"key":"BFejhg2012278_CR31","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","volume":"25","author":"DD Anh","year":"2007","unstructured":"Anh DD, Canh do G, Lopez AL et al: Safety and immunogenicity of a reformulated Vietnamese bivalent killed whole-cell oral cholera vaccine in adults. Vaccine 2007; 25: 1149\u20131155.","journal-title":"Vaccine"},{"key":"BFejhg2012278_CR32","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.4049\/jimmunol.167.9.5067","volume":"167","author":"B Pulendran","year":"2001","unstructured":"Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J : Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001; 167: 5067\u20135076.","journal-title":"J Immunol"},{"key":"BFejhg2012278_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1479-5876-1-8","volume":"1","author":"P Jin","year":"2003","unstructured":"Jin P, Wang E : Polymorphism in clinical immunology\u2014from HLA typing to immunogenetic profiling. J Transl Med 2003; 1: 8.","journal-title":"J Transl Med"},{"key":"BFejhg2012278_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11568-010-9134-1","volume":"3","author":"PP Majumder","year":"2009","unstructured":"Majumder PP, Staats HF, Sarkar-Roy N et al: Genetic determinants of immune-response to a polysaccharide vaccine for typhoid. HUGO J 2009; 3: 17\u201330.","journal-title":"HUGO J"},{"key":"BFejhg2012278_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00439-011-0977-x","volume":"130","author":"IG Ovsyannikova","year":"2011","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA : The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011; 130: 547\u2013561.","journal-title":"Hum Genet"},{"key":"BFejhg2012278_CR36","first-page":"277","volume":"38","author":"AS Benenson","year":"1968","unstructured":"Benenson AS, Saad A, Mosley WH : Serological studies in cholera 2 The vibriocidal antibody response of cholera patients determined by a microtechnique. Bull World Health Organ 1968; 38: 277\u2013285.","journal-title":"Bull World Health Organ"},{"key":"BFejhg2012278_CR37","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1504\/IJDMB.2011.045418","volume":"5","author":"N Sarkar-Roy","year":"2011","unstructured":"Sarkar-Roy N, Mondal D, Bhattacharya P, Majumder P : A novel statistical algorithm for enhancing the utility of HapMap data to design genomic association studies in non-HapMap populations. Int J Data Mining Bioinf 2011; 5: 706\u2013716.","journal-title":"Int J Data Mining Bioinf"},{"key":"BFejhg2012278_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D : Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904\u2013909.","journal-title":"Nat Genet"},{"key":"BFejhg2012278_CR39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y : Controlling the false discovery rate a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B Methodological 1995; 57: 289\u2013300.","journal-title":"J Roy Statist Soc Ser B Methodological"},{"key":"BFejhg2012278_CR40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1086\/522036","volume":"81","author":"KN Conneely","year":"2007","unstructured":"Conneely KN, Boehnke M : So many correlated tests so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 2007; 81: 1158\u20131168.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2012278_CR41","doi-asserted-by":"publisher","first-page":"e1000456","DOI":"10.1371\/journal.pgen.1000456","volume":"5","author":"B Han","year":"2009","unstructured":"Han B, Kang HM, Eskin E : Rapid and accurate multiple testing correction and power estimation for millions of correlated markers. PLoS Genet 2009; 5: e1000456.","journal-title":"PLoS Genet"},{"key":"BFejhg2012278_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith N, Donnelly P : A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978\u2013989.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2012278_CR43","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","volume":"21","author":"FO Eko","year":"2003","unstructured":"Eko FO, Schukovskaya T, Lotzmanova EY et al: Evaluation of the protective efficacy of Vibrio cholerae ghost VCG; candidate vaccines in rabbits. Vaccine 2003; 21: 3663\u20133674.","journal-title":"Vaccine"},{"key":"BFejhg2012278_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1128\/CVI.05689-11","volume":"19","author":"AA Tarique","year":"2012","unstructured":"Tarique AA, Kalsy A, Arifuzzaman M et al: Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Clin Vaccine Immunol 2012; 19: 594\u2013602.","journal-title":"Clin Vaccine Immunol"},{"key":"BFejhg2012278_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","volume":"363","author":"DA Sack","year":"2004","unstructured":"Sack DA, Sack RB, Nair GB, Siddique AK : Cholera. Lancet 2004; 363: 223\u2013233.","journal-title":"Lancet"},{"key":"BFejhg2012278_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1128\/CMR.8.1.48","volume":"8","author":"JB Kaper","year":"1995","unstructured":"Kaper JB, Morris JG, Levine MM : Cholera. Clin Microbiol Rev 1995; 8: 48\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"BFejhg2012278_CR47","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","volume":"163","author":"JD Clemens","year":"1991","unstructured":"Clemens JD, van Loon F, Sack DA et al: Field trial of oral cholera vaccines in Bangladesh serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis 1991; 163: 1235\u20131242.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR48","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1086\/421275","volume":"189","author":"D Saha","year":"2004","unstructured":"Saha D, LaRocque RC, Khan AI et al: Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J Infect Dis 2004; 189: 2318\u20132322.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.64.1.10-15.1996","volume":"64","author":"GA Losonsky","year":"1996","unstructured":"Losonsky GA, Yunyongying J, Lim V et al: Factors influencing secondary vibriocidal immune responses Relevance for understanding immunity to cholera. Infect Immun 1996; 64: 10\u201315.","journal-title":"Infect Immun"},{"key":"BFejhg2012278_CR50","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/CVI.00562-10","volume":"18","author":"MM Alam","year":"2011","unstructured":"Alam MM, Riyadh MA, Fatema K et al: Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally. Clin Vaccine Immunol 2011; 18: 844\u2013850.","journal-title":"Clin Vaccine Immunol"},{"key":"BFejhg2012278_CR51","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1128\/CVI.05615-11","volume":"19","author":"DT Leung","year":"2012","unstructured":"Leung DT, Rahman MA, Mohasin M et al: Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh. Clin Vaccine Immunol 2012; 19: 690\u2013698.","journal-title":"Clin Vaccine Immunol"},{"key":"BFejhg2012278_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1741-7007-8-129","volume":"8","author":"MM Levine","year":"2010","unstructured":"Levine MM : Immunogenicity and efficacy of oral vaccines in developing countries lessons from a live cholera vaccine. BMC Biol 2010; 8: 129.","journal-title":"BMC Biol"},{"key":"BFejhg2012278_CR53","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni0910-769","volume":"11","author":"AC Serazin","year":"2010","unstructured":"Serazin AC, Shackelton LA, Wilson C, Bhan MK : Improving the performance of enteric vaccines in the developing world. Nat Immunol 2010; 11: 769\u2013773.","journal-title":"Nat Immunol"},{"key":"BFejhg2012278_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/gene.2009.2","volume":"10","author":"RC LaRocque","year":"2009","unstructured":"LaRocque RC, Sabeti P, Duggal P et al: A variant in long palate lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun 2009; 10: 267\u2013272.","journal-title":"Genes Immun"},{"key":"BFejhg2012278_CR55","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/infdis\/jir544","volume":"204","author":"OS Shin","year":"2011","unstructured":"Shin OS, Uddin T, Citorik R et al: LPLUNC1 modulates innate immune responses to Vibrio cholera. J Infect Dis 2011; 204: 1349\u20131357.","journal-title":"J Infect Dis"},{"key":"BFejhg2012278_CR56","doi-asserted-by":"publisher","first-page":"G968","DOI":"10.1152\/ajpgi.00208.2011","volume":"301","author":"KA Agle","year":"2011","unstructured":"Agle KA, Vongsa RA, Dwinell MB : Chemokine stimulation promotes enterocyte migration through laminin-specific integrins. Am J Physiol Gastrointest Liver Physiol 2011; 301: G968\u2013G980.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFejhg2012278_CR57","doi-asserted-by":"publisher","first-page":"e7806","DOI":"10.1371\/journal.pone.0007806","volume":"4","author":"G Ou","year":"2009","unstructured":"Ou G, Rompikuntal PK, Bitar A et al: Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the prtv protease. PLoS ONE 2009; 4: e7806.","journal-title":"PLoS ONE"},{"key":"BFejhg2012278_CR58","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","volume":"103","author":"A Poggi","year":"2003","unstructured":"Poggi A, Carosio R, Fenoglio D et al: Migration of V\u03b41 and V\u03b42T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1\u2013infected patients competition by HIV-1 Tat. Blood 2003; 103: 2205\u20132213.","journal-title":"Blood"},{"key":"BFejhg2012278_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrmicro1126","volume":"3","author":"RG Jennner","year":"2005","unstructured":"Jennner RG, Young RA : Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005; 3: 281\u2013294.","journal-title":"Nat Rev Microbiol"},{"key":"BFejhg2012278_CR60","doi-asserted-by":"publisher","first-page":"e26352","DOI":"10.1371\/journal.pone.0026352","volume":"6","author":"LE Kolodziej","year":"2011","unstructured":"Kolodziej LE, Lodolce JP, Chang JE et al: TNFAIP2 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One 2011; 6: e26352.","journal-title":"PLoS One"},{"key":"BFejhg2012278_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gene.2008.99","volume":"10","author":"EY Fung","year":"2009","unstructured":"Fung EY, Smyth DJ, Howson JM et al: Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23\/TNFAIP3 as a susceptibility locus. Genes Immunity 2009; 10: 188\u2013191.","journal-title":"Genes Immunity"},{"key":"BFejhg2012278_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1286-4579(00)00296-3","volume":"2","author":"G Kraal","year":"2000","unstructured":"Kraal G, van der Laan LJW, Elomaa O, Tryggvason K : The macrophage receptor MARCO. Microbes Infect 2000; 2: 313\u2013316.","journal-title":"Microbes Infect"},{"key":"BFejhg2012278_CR63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4049\/jimmunol.162.2.939","volume":"162","author":"LJW Van der Laan","year":"1999","unstructured":"Van der Laan LJW, Dopp EA, Haworth R et al: Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999; 162: 939\u2013947.","journal-title":"J Immunol"},{"key":"BFejhg2012278_CR64","doi-asserted-by":"publisher","first-page":"33378","DOI":"10.1074\/jbc.M204494200","volume":"277","author":"M Sankala","year":"2002","unstructured":"Sankala M, Br\u00e4nnstr\u00f6m A, Schulthess T et al: Characterization of Recombinant Soluble Macrophage Scavenger Receptor MARCO. J Biol Chem 2002; 277: 33378\u201333385.","journal-title":"J Biol Chem"},{"key":"BFejhg2012278_CR65","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/CVI.00562-10","volume":"18","author":"MM Alam","year":"2011","unstructured":"Alam MM, Riyadh MA, Fatema K et al: Antigen-specific memory B-cell responses in bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vac Immuol 2011; 18: 844\u2013850.","journal-title":"Clin Vac Immuol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012278","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:33:29Z","timestamp":1714750409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2012278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["BFejhg2012278"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.278","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}